Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
---|
04/04/2013 | WO2013045737A1 Immunogenic gluten peptides and uses thereof |
04/04/2013 | WO2013045600A1 Novel peptide derivatives as antibiotics |
04/04/2013 | WO2013044499A1 Use of hepatitis c virus immunogenic peptide or its derivative in preparing medicine for preventing or treating colitis |
04/04/2013 | US20130086701 Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors |
04/04/2013 | US20130085261 Binding partners of antibodies specific for dendritic cell antigens |
04/04/2013 | US20130085188 Peptide networks |
04/04/2013 | US20130085108 Peptides for promoting angiogenesis and an use thereof |
04/04/2013 | US20130085107 Treatments for Gastrointestinal Disorders |
04/04/2013 | US20130085105 Transdermal Administration Of Peptides |
04/04/2013 | US20130084618 Phenolic binding peptides |
04/04/2013 | US20130084303 Peptides shared among lethal cancers and therapeutic compositions comprising said peptides |
04/04/2013 | US20130084283 Oligomer-specific amyloid beta epitope and antibodies |
04/04/2013 | CA2845735A1 Novel peptide derivatives as antibiotics |
04/03/2013 | CN103025754A Novel jnk inhibitor molecules |
04/03/2013 | CN103014880A Novel affinity ligand polypeptide library of immunoglobulin G constructed based on protein A affinity model and application of design method |
04/03/2013 | CN103012565A Triptorelin and solid-phase synthesis preparation method thereof |
04/03/2013 | CN103012564A High-purity triptorelin and purification method thereof |
04/03/2013 | CN103012563A Solid-phase synthesis method of antibacterial peptide Iseganan |
04/03/2013 | CN103012562A Dual-targeting D-configuration polypeptides and drug delivery system thereof |
04/03/2013 | CN103012561A Small peptide for tumor targeted diagnosis |
04/03/2013 | CN103012560A Preparation method of cyclic peptide compound from cortex lycii radicis |
04/03/2013 | CN103012559A Peptaibol compound and application thereof |
04/03/2013 | CN103012558A Cation symmetrical amphipathic self-assembled polypeptide and application thereof |
04/03/2013 | CN103012557A Caffeoyl-alpha-neoendorphin peptide derivative and use thereof as an anti-itch and anti-atopic material |
04/03/2013 | CN103012556A Method for synthesizing growth hormone secretagogue pentapeptide from solid phase polypeptide |
04/03/2013 | CN103012555A Preparation method for new polypeptide having tissue protection activity, and application of new polypeptide in treatment |
04/03/2013 | CN102219828B Antioxidation polypeptide prepared from sharkskin collagen |
04/03/2013 | CN102127148B Polypeptide in cluster-of-differentiation part on surface of vascular endothelial cell and use thereof |
04/03/2013 | CN102120755B Brown adipose tissue targeted polypeptide and applications thereof |
04/03/2013 | CN101775429B Whey protein antioxidant peptides, preparation method thereof and application thereof |
04/03/2013 | CN101525377B Method for separating and purifying method of polymyxin E methanesulfonic sodium |
04/03/2013 | CN101421417B PCR hot start by magnesium sequestration |
04/03/2013 | CN101313063B Cancer-rejection antigen peptide derived from glypican-3 (GPC3) for use in HLA-A2-positive patient and pharmaceutical comprising the antigen |
04/02/2013 | US8410059 CXCR4 antagonist and use thereof |
04/02/2013 | US8410046 Antibiotic peptide derived from ribosomal protein L1 of Helicobacter pylori and use thereof |
04/02/2013 | US8410045 Camptothecin-peptide conjugates and pharmaceutical compositions containing the same |
04/02/2013 | US8409858 Modular functional peptides for the intracellular delivery of nanoparticles |
04/02/2013 | US8409581 Compounds for treating amyloidoses |
04/02/2013 | US8409580 Therapeutic vaccine targeted against P-glycoprotein 170 for inhibiting multidrug resistance in the treatment of cancers |
04/02/2013 | CA2546498C Peptide increasing fusiogenic capacity of a gamete |
04/02/2013 | CA2449412C Receptor-mediated uptake of peptides that bind the human transferrin receptor |
04/02/2013 | CA2201282C Viral material and nucleotide fragments associated with multiple sclerosis useful for diagnostic, preventive and therapeutic purposes |
03/28/2013 | WO2013042811A1 Caffeoyl alpha neoendorphin peptide derivative and use thereof as an anti-itch and anti-atopic material |
03/28/2013 | WO2013041899A1 Foldamers containing cyclic gamma amino acid residues, eventually alternating with alpha- aminoisobutyric acid |
03/28/2013 | WO2012165900A3 Peptide bfp 4 for promoting bone formation or vasculogenesis, and application therefor |
03/28/2013 | US20130079493 Method for prepairing peptide inhibitors of a lipid-activated enzyme and peptides produced by same |
03/28/2013 | US20130079292 Cyclic peptides binding cxcr4 receptor and relative medical and diagnostic uses |
03/28/2013 | US20130079287 Caffeoylalphaneoendorphin peptide derivative and use thereof as anti-itching and anti-atopic agents |
03/28/2013 | US20130078741 Iga-binding peptide and purification of iga using the same |
03/28/2013 | US20130078280 Cyclosporine analogue mixtures and their use as immunomodulating agents |
03/28/2013 | CA2849100A1 Srm/mrm assay for the fatty acid synthase protein |
03/27/2013 | EP2573103A1 Peptide domains that bind small molecules of industrial significance |
03/27/2013 | EP2573102A1 Peptide domains that bind small molecules of industrial significance |
03/27/2013 | EP2573083A1 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
03/27/2013 | EP2572724A1 Treatment of fibrosis and liver diseases |
03/27/2013 | EP2571893A1 Novel cyclodecapeptide compounds for use as drugs |
03/27/2013 | EP2571510A1 Biosynthetic proline/alanine random coil polypeptides and their uses |
03/27/2013 | EP2571362A1 Improved process for a folate-targeted agent |
03/27/2013 | CN103003294A Gene fusion targeted therapy |
03/27/2013 | CN102993302A Novel anti-Il 13 antibodies and uses thereof |
03/27/2013 | CN102993274A Purification method of ganirelix acetate |
03/27/2013 | CN102993273A Application of monodisperse polymethacrylate strong anion exchange chromatography media to purification of daptomycin |
03/27/2013 | CN102993272A Targeted peptide of epidermal growth factor receptor (EGFR) and application thereof |
03/27/2013 | CN102993265A Immune receptor regulator couplet as well as preparation method and application thereof, coupling precursor for preparing immune receptor regulator couplet and compound for compounding coupling precursor |
03/27/2013 | CN102988193A Medical beautifying polypeptide capable of promoting cell regeneration and delaying skin aging |
03/27/2013 | CN102603869B Synthetic method of hexapeptide |
03/27/2013 | CN102321158B Polypeptide for preventing cell DNA synthesis and inhibiting cell proliferation and application |
03/27/2013 | CN102225965B Substituted tetrahydro-isoquinoline-3-carboxylic acid compound, preparation method and application thereof |
03/27/2013 | CN102206247B Novel peptides as NS3/NS4a serine protease inhibitors of hepatitis C virus |
03/27/2013 | CN102120757B Hybrid peptide using 3S-tetrahydro-beta-carboline-3-carboxylic acid as connecting arm, and preparation method and application thereof |
03/27/2013 | CN102030818B Peptide inhibiting angiontensin converting enzyme |
03/27/2013 | CN101991848B Synthetic peptide vaccine for swine fever and application thereof |
03/27/2013 | CN101906464B Proteins producing an altered immunogenic response and methods of making and using the same |
03/27/2013 | CN101897961B Preparation method for B cell CD 22 extracellular inhibitive peptide fragment B2285 vaccines |
03/27/2013 | CN101607985B Monoclonal antibody for anti-human CEA, a composition containing same and application thereof |
03/27/2013 | CN101296939B Peptides for promoting hair growth and improving wrinkle and cosmetic compositions comprising the same |
03/27/2013 | CN101287748B Compositions and methods for fusion protein separation |
03/27/2013 | CN101052408B Peptides that selectively home to heart vasculature and related conjugates and methods |
03/27/2013 | CN101037472B LHRH antagonist with low-histamine releasing function |
03/26/2013 | US8404802 a targeting vector which binds to receptors associated with integrin receptors, angiogenesis; contrast agents; diagnosis of malignant diseases, heart diseases, inflammation-related diseases, rheumatoid arthritis and Kaposi's sarcoma |
03/26/2013 | US8404635 Orally administered peptides synergize statin activity |
03/26/2013 | CA2485169C Peptide derivatives, and their use for the synthesis of silicon-based composite materials |
03/21/2013 | WO2013039190A1 Peptide-containing polymer, and method for peptide immobilization on fiber |
03/21/2013 | WO2013038392A1 Peptides useful for binding to b-cell leukemic cells, conjugates, and compositions comprising same and uses thereof |
03/21/2013 | WO2013038201A1 Short designed peptides possessing selective actions against bacteria and cancer cells |
03/21/2013 | WO2013038022A1 Method for characterizing bacteria by detection of non-structural bacteriophage proteins |
03/21/2013 | WO2013037714A1 BIOMARKERS FOR BREAST TUMOURS FROM Hsp70-ASSOCIATED PEPTIDES |
03/21/2013 | US20130072660 Identification and use of novopeptides for the treatment of cancer |
03/21/2013 | US20130072581 Secreted Protein Acidic and Rich in Cysteine (SPARC) Protein SRM Assay |
03/21/2013 | US20130072444 Organic compound for the regulation of vectorial ion channels |
03/21/2013 | US20130072439 Peptidomimetic macrocycles |
03/21/2013 | US20130072433 Inhibitors of beta integrin-g protein alpha subunit binding interactions |
03/21/2013 | US20130072431 Cardiovascular therapeutics |
03/21/2013 | US20130072425 Saposin-a derived peptides and uses thereof |
03/21/2013 | US20130072400 Method for the diagnosis/prognosis of colorectal cancer |
03/21/2013 | US20130071428 Peptides, conjugates and method for increasing immunogenicity of a vaccine |
03/21/2013 | US20130071424 Peptides mimicking hiv-1 viral epitopes in the v2 loop for the gp120 surface envelope glycoprotein |
03/20/2013 | EP2569633A2 Compositions and methods of identifying tumor specific neoantigens |
03/20/2013 | EP2569327A1 Eif4e binding peptides |
03/20/2013 | EP2569326A2 Peptide-based inhibitor of interleukin-10 or interferon-gamma signaling |